Correlation Between Vincerx Pharma and Tenaya Therapeutics
Can any of the company-specific risk be diversified away by investing in both Vincerx Pharma and Tenaya Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vincerx Pharma and Tenaya Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vincerx Pharma and Tenaya Therapeutics, you can compare the effects of market volatilities on Vincerx Pharma and Tenaya Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vincerx Pharma with a short position of Tenaya Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vincerx Pharma and Tenaya Therapeutics.
Diversification Opportunities for Vincerx Pharma and Tenaya Therapeutics
0.36 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Vincerx and Tenaya is 0.36. Overlapping area represents the amount of risk that can be diversified away by holding Vincerx Pharma and Tenaya Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tenaya Therapeutics and Vincerx Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vincerx Pharma are associated (or correlated) with Tenaya Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tenaya Therapeutics has no effect on the direction of Vincerx Pharma i.e., Vincerx Pharma and Tenaya Therapeutics go up and down completely randomly.
Pair Corralation between Vincerx Pharma and Tenaya Therapeutics
Given the investment horizon of 90 days Vincerx Pharma is expected to under-perform the Tenaya Therapeutics. In addition to that, Vincerx Pharma is 2.36 times more volatile than Tenaya Therapeutics. It trades about -0.59 of its total potential returns per unit of risk. Tenaya Therapeutics is currently generating about -0.38 per unit of volatility. If you would invest 142.00 in Tenaya Therapeutics on November 2, 2024 and sell it today you would lose (36.00) from holding Tenaya Therapeutics or give up 25.35% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Vincerx Pharma vs. Tenaya Therapeutics
Performance |
| Timeline |
| Vincerx Pharma |
| Tenaya Therapeutics |
Vincerx Pharma and Tenaya Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Vincerx Pharma and Tenaya Therapeutics
The main advantage of trading using opposite Vincerx Pharma and Tenaya Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vincerx Pharma position performs unexpectedly, Tenaya Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tenaya Therapeutics will offset losses from the drop in Tenaya Therapeutics' long position.| Vincerx Pharma vs. Spero Therapeutics | Vincerx Pharma vs. Bolt Biotherapeutics | Vincerx Pharma vs. Coherus BioSciences | Vincerx Pharma vs. Applied Therapeutics |
| Tenaya Therapeutics vs. Bicycle Therapeutics | Tenaya Therapeutics vs. IGM Biosciences | Tenaya Therapeutics vs. Monte Rosa Therapeutics | Tenaya Therapeutics vs. Stoke Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |